
浏览全部资源
扫码关注微信
400042 重庆,第三军医大学新桥医院肝胆外科
[ 尤楠,E-mail:younan330@hotmail.com YOU Nan, E-mail: younan330@hotmail.com
[ 李靖,E-mail:jinglixq@yeah.net LI Jing, E-mail:jinglixq@yeah.net
收稿:2017-02-24,
修回:2017-03-26,
纸质出版:2017-09-15
移动端阅览
谭烨, 尤楠, 郑璐, 等. COMMD7调控肝癌干细胞间充质-上皮转化过程抑制其侵袭转移能力[J]. 第三军医大学学报, 2017,39(17):1691-1695.
Ye TAN, Nan YOU, Lu ZHENG, et al. COMMD7 inhibits migration and invasion in liver cancer stem cells
谭烨, 尤楠, 郑璐, 等. COMMD7调控肝癌干细胞间充质-上皮转化过程抑制其侵袭转移能力[J]. 第三军医大学学报, 2017,39(17):1691-1695. DOI: 10.16016/j.1000-5404.201702131.
Ye TAN, Nan YOU, Lu ZHENG, et al. COMMD7 inhibits migration and invasion in liver cancer stem cells
目的
2
探讨抑制COMMD7基因后对肝癌干细胞(liver cancer stem cells,LCSCs)侵袭转移能力的影响及其机制。
方法
2
使用shRNA慢病毒转染抑制COMMD7在LCSCs中的表达,粘附、Transwell实验检测细胞侵袭迁移能力,鬼笔环肽染色检测细胞形态学特征,Western blot检测细胞中E-cadherin、N-cadherin、Vimentin蛋白表达。
结果
2
抑制COMMD7基因表达可以显著降低LCSCs的侵袭迁移能力,对照组与转染组粘附相对细胞量为(1.00±0.12),(2.35± 0.20),转染组粘附细胞数量显著增加(
P
<0.05)。对照组与转染组每视野迁移相对细胞量为(1.00±0.04),(0.24±0.03),每视野侵袭相对细胞量为(1.00±0.05),(0.24±0.04),转染组迁移侵袭细胞数明显降低(
P
<0.05),同时导致细胞表现出低侵袭迁移能力的形态学变化,上述改变伴随了间充质-上皮转化(mesenchymal-epithelial transition,MET)相关分子E-cadherin表达上升(
P
<0.05),N-cadherin、Vimentin表达下调(
P
<0.05)。
结论
2
COMMD7可能通过调控MET过程抑制LCSCs的侵袭转移能力。
Objective
2
To determine the effect of COMMD7 inhibition on invasion and migration in liver cancer stem cells (LCSCs)
and investigate the possible mechanism.
Methods
2
After LCSCs were infected by shRNA lentiviral vectors of COMMD7
adhesion assay and Transwell assay were used to detect the invasion and migration
and phalloidin staining was employed to observe the morphological changes. Western blotting was adopted to measure the expression of E-cadherin
N-cadherin and Vimentin.
Results
2
COMMD7 knockdown significantly inhibited the invasion and migration of LCSCs. The relative cell quantity of adhesion was 1.00±0.12 and 2.35±0.20 respectively in control cells and infected cells
suggesting there were significantly more adhesive cells in the infected group (
P
<
0.05). The relative cell quantity per visual field of migration was 1.00±0.04 and 0.24±0.03
and that of invasion was 1.00±0.05 and 0.24±0.04 respectively in the control cells and infected cells
and there were significantly less invasive and migrated cells in the infected group (
P
<
0.05). What ' s more
COMMD7
knockdown also induced some morphological changes of cells corresponding to the weakened abilities of migration and invasion. All the changes above were associated with up-regulation of E-cadherin (
P
<
0.05) and down-regulation of N-cadherin and Vimentin (
P
<
0.05)
the molecules related to mesenchymal-epithelial transition (MET).
Conclusion
2
COMMD7 knockdown inhibits the invasion and migration in LCSCs
which may be through its regulation on the MET course.
SUN J H, LUO Q, LIU L L, et al . Liver cancer stem cell markers: progression and therapeutic implications[J]. World J Gastroenterol,2016,22(13):3547-3557.DOI: 10.3748/wjg.v22.i13.3547.
LIU W H, WANG X, YOU N, et al . Efficient enrichment of hepatic cancer stem like cells from a primary rat HCC model via a density gradient centrifugation centered method[J]. PLoS One,2012,7(4):e35720. DOI: 10.1371/journal.pone.0035720.
YOU N , ZHENG L, LIU W, et al . Proliferation inhibition and differentiation induction of hepatic cancer stem cells by knockdown of BC047440: a potential therapeutic target of stem cell treatment for hepatocellular carcinoma[J]. Oncol Rep, 2014,31(4):1911-1920.DOI: 10.3892/or.2014.3043.
FIFE C M, MCCARROLL J A, KAVALLARIS M. Movers and shakers: cell cytoskeleton in cancer metastasis[J]. Br J Pharmacol, 2014,171(24):5507-5523.DOI: 10.1111/bph.12704.
MAGEE J A, PISKOUNOVA E, MORRISON S J. Cancer stem cells: impact, heterogeneity, and uncertainty[J]. Cancer Cell, 2012,21(3):283-296. DOI: 10.1016/j.ccr.2012.03.003.
YAMASHITA T , WANG X W. Cancer stem cells in the development of liver cancer[J]. J Clin Invest,2013,123(5):1911-1918. DOI: 10.1172/JCI66024.
ZHENG L, LIANG P, LI J, et al . ShRNA targeted COMMD7 suppresses hepatocellular carcinoma growth[J]. PLoS One, 2012,7(9):e45412. DOI: 10.1371/journal.pone.0045412.
王峥, 郑璐, 黄小兵, 等. 慢病毒介导BC047440基因沉默逆转HepG2/ADM细胞化疗耐药性机制的探讨[J]. 第三军医大学学报, 2012, 34(8): 705-709. DOI:10.16016/j.1000 5404.2012.04.016.
WANG Z, ZHENG L, HUANG X B, et al . Mechanism underlying drug resistance of HepG2/ADM cells silently reversed by lentivirus mediated BC047440 gene during chemotherapy[J]. J Third Mil Med Univ, 2012, 34(8): 705-709. DOI:10.16016/j.1000 5404.2012.04.016.
ZHENG L, LIANG P, ZHOU J, et al . BC047440 antisense eukaryotic expression vectors inhibited HepG2 cell proliferation and suppressed xenograft tumorigenicity[J]. Braz J Med Biol Res, 2012,45(2):97-103.
YOU N, LI J, HUANG X, et al . COMMD7 promotes hepatocellular carcinoma through regulating CXCL10[J]. Biomed Pharmacother,2017,88:653-657. DOI: 10.1016/j.biopha.2017.01.046.
SMITH B N, BHOWMICK N A. Role of EMT in metastasis and therapy resistance[J]. J Clin Med,2016,5(2): E17. DOI: 10.3390/jcm5020017.
OTA I, MASUI T, KURIHARA M, et al . Snail induced EMT promotes cancer stem cell like properties in head and neck cancer cells[J]. Oncol Rep,2016,35(1):261-266.DOI: 10.3892/or.2015.4348.
CANEL M, SERRELS A, FRAME M C, et al . E cadherin integrin crosstalk in cancer invasion and metastasis[J]. J Cell Sci, 2013,126(Pt 2):393-401. DOI: 10.1242/jcs.100115.
NGUYEN T, MEGE R M. N Cadherin and fibroblast growth factor receptors crosstalk in the control of developmental and cancer cell migrations[J]. Eur J Cell Biol, 2016,95(11): 415-426. DOI: 10.1016/j.ejcb.2016.05.002.
BRZOZOWA M, WYROBIEC G, KOLODIEJ I, et al . The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract[J]. Prz Gastroenterol, 2015,10(1):7-11.DOI: 10.5114/pg.2014.47502.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621